Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Solomon

Showing results (1541-1550 of 1,873) with videos related to

Pageof 188
Sort By:
Circulation. Heart Failure|December 22, 2012
Baseline characteristics of patients in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trialSanjiv J Shah, John F Heitner, Nancy K Sweitzer, et al.
Journal of the American College of Cardiology|April 23, 2021
Incidence and Outcomes of Pneumonia in Patients With Heart FailureLi Shen, Pardeep S Jhund, Inder S Anand, et al.
JACC. Heart Failure|September 16, 2022
Influence of NT-proBNP on Efficacy of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection FractionPeder L Myhre, Muthiah Vaduganathan, Brian L Claggett, et al.
European Journal of Heart Failure|August 26, 2023
Influence of background medical therapy on efficacy and safety of dapagliflozin in patients with heart failure with improved ejection fraction in the DELIVER trialMaria Pabon, Brian L Claggett, Xiaowen Wang, et al.
JACC. Heart Failure|January 6, 2026
Subgroups and Special Populations in Heart Failure Clinical Trials: Insights From the HFC-ARC Expert Consensus PanelVanessa Blumer, Biykem Bozkurt, Marvin A Konstam, et al.
JACC. Heart Failure|May 10, 2024
Cause-Specific Health Care Costs Following Hospitalization for Heart Failure and Cost Offset With SGLT2i TherapyVeraprapas Kittipibul, Muthiah Vaduganathan, Uchechukwu Ikeaba, et al.
JACC. Advances|July 18, 2025
Minimum Core Data Elements for Evaluation of Thoracic Aortic DiseaseAndreina Carbone, Mary J Roman, Melissa L Russo, et al.
American Heart Journal|June 18, 2018
High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trialOrly Vardeny, Jacob A Udell, Jacob Joseph, et al.
Hypertension (Dallas, Tex. : 1979)|December 4, 2023
Cardiac Abnormalities in Hispanic/Latina Women With Prior De Novo Hypertensive Disorders of PregnancyOdayme Quesada, Shathiyah Kulandavelu, Catherine J Vladutiu, et al.
Journal of the American College of Cardiology|October 1, 2024
Finerenone in Patients With a Recent Worsening Heart Failure Event: The FINEARTS-HF TrialAkshay S Desai, Muthiah Vaduganathan, Brian L Claggett, et al.
Pageof 188

Showing results (1541-1550 of 1,873) with videos related to

Sort By:
Pageof 188
Circulation. Heart Failure|December 22, 2012
Baseline characteristics of patients in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trialSanjiv J Shah, John F Heitner, Nancy K Sweitzer, et al.
Journal of the American College of Cardiology|April 23, 2021
Incidence and Outcomes of Pneumonia in Patients With Heart FailureLi Shen, Pardeep S Jhund, Inder S Anand, et al.
JACC. Heart Failure|September 16, 2022
Influence of NT-proBNP on Efficacy of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection FractionPeder L Myhre, Muthiah Vaduganathan, Brian L Claggett, et al.
European Journal of Heart Failure|August 26, 2023
Influence of background medical therapy on efficacy and safety of dapagliflozin in patients with heart failure with improved ejection fraction in the DELIVER trialMaria Pabon, Brian L Claggett, Xiaowen Wang, et al.
JACC. Heart Failure|January 6, 2026
Subgroups and Special Populations in Heart Failure Clinical Trials: Insights From the HFC-ARC Expert Consensus PanelVanessa Blumer, Biykem Bozkurt, Marvin A Konstam, et al.
JACC. Heart Failure|May 10, 2024
Cause-Specific Health Care Costs Following Hospitalization for Heart Failure and Cost Offset With SGLT2i TherapyVeraprapas Kittipibul, Muthiah Vaduganathan, Uchechukwu Ikeaba, et al.
JACC. Advances|July 18, 2025
Minimum Core Data Elements for Evaluation of Thoracic Aortic DiseaseAndreina Carbone, Mary J Roman, Melissa L Russo, et al.
American Heart Journal|June 18, 2018
High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trialOrly Vardeny, Jacob A Udell, Jacob Joseph, et al.
Hypertension (Dallas, Tex. : 1979)|December 4, 2023
Cardiac Abnormalities in Hispanic/Latina Women With Prior De Novo Hypertensive Disorders of PregnancyOdayme Quesada, Shathiyah Kulandavelu, Catherine J Vladutiu, et al.
Journal of the American College of Cardiology|October 1, 2024
Finerenone in Patients With a Recent Worsening Heart Failure Event: The FINEARTS-HF TrialAkshay S Desai, Muthiah Vaduganathan, Brian L Claggett, et al.
Pageof 188